Related Experiment Video
Updated: Mar 29, 2026
05:30
Author Spotlight: Exploring the Potential of Fat-Derived Stromal Vascular Fraction for Wound Healing
Published on: November 17, 2023
1.2K
Imaging the Stromal Vascular Fraction during Soft-Tissue Reconstruction
Jacqueline M Bliley1, Latha Satish, Meghan M McLaughlin
1Pittsburgh, Pa. From the Departments of Plastic Surgery and Bioengineering, University of Pittsburgh; and the McGowan Institute for Regenerative Medicine.
Plastic and Reconstructive Surgery
|November 24, 2015
Summary
Stromal vascular fraction (SVF) enrichment improves fat graft retention. Near-infrared dye labeling of SVF allowed in vivo tracking and confirmed its presence in fat grafts for up to 41 days, supporting its use in regenerative medicine.
Area of Science:
- Regenerative Medicine
- Biomedical Imaging
- Tissue Engineering
Background:
- Suboptimal volume retention is a key challenge in fat grafting procedures.
- Enriching fat grafts with stromal vascular fraction (SVF) is a promising strategy to enhance graft survival and retention.
- Limited research exists on the in vivo fate and impact of transplanted SVF within fat grafts.
Purpose of the Study:
- To investigate the in vivo fate of SVF when used to enrich fat grafts.
- To assess the impact of near-infrared dye labeling on SVF cellular function.
- To utilize in vivo imaging techniques to track SVF localization and persistence within fat grafts.
Main Methods:
- Stromal vascular fraction (SVF) cells were labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide (DiR), a near-infrared fluorescent dye.
- Cell proliferation and differentiation assays were performed to ensure labeling did not compromise SVF function.
- In vivo imaging systems were employed to track the distribution and persistence of labeled SVF within fat grafts over time, using varying cell doses.
Main Results:
- DiR labeling did not significantly affect SVF proliferation or differentiation compared to unlabeled cells (p > 0.05).
- Pilot studies confirmed successful localization of fluorescently labeled SVF within fat grafts and the ability to distinguish between different cell doses.
- In vivo tracking demonstrated statistically significant fluorescence in fat grafts correlating with SVF cell dose, with higher doses (3 × 10^6 and 2 × 10^6 cells/ml) persisting for up to 41 days (p < 0.05).
Conclusions:
- DiR labeling is a suitable method for tracking SVF in vivo, allowing differentiation between cell doses and confirmation of graft localization.
- In vivo imaging combined with DiR labeling provides a valuable tool for studying SVF behavior within fat grafts.
- This approach supports the use of SVF enrichment to improve fat graft outcomes in regenerative medicine applications.
